Neurotrophic effects of lithium stimulate the reduction of ischemic and neurodegenerative brain damage

Pronin A.V.; Gogoleva I.V.; Torshin I.Yu.; Gromova O.A.

doi:https://doi.org/10.17116/jnevro20161162199-108

References:

Goodwin FK. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder. J Clin Psychiatry. 2003;64(suppl 5):18-24.
Lin D, Mok H, Yatham LN. Polytherapy in bipolar disorder. CNS Drugs. 2006;20:29-42. https://doi.org/10.2165/00023210-200620010-00003
Tondo L, Baldessarini RJ. Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiol Psichiatr Soc. 2009;18:179-183.
Avcyn AP, Zhavoronkov AA, Rish MA, Strochkova LS. Mikrojelementozy cheloveka. M.: Medicina; 1991. (In Russ.).
Jagodin BA. Kol’co zhizni: Agrohimicheskij vestnik. 1998;3:10-13. (In Russ.).
Gildengers AG, Butters MA, Aizenstein HJ, Marron MM, Emanuel J, Anderson SJ, Weissfeld LA, Becker JT, Lopez OL, Mulsant BH, Reynolds CF 3rd. Longer lithium exposure is associated with better white matter integrity in older adults with bipolar disorder. Bipolar Disord. 2014. https://doi.org/10.1111/bdi.12260
Gogoleva IV. The influence of organic salts of lithium, magnesium and selenium in elemental homeostasis of the brain on the background of experimental chronic bilateral occlusion of common carotid arteries. [dissertation]. M. 2009.
Zangieva ZK, Torshin IJu, Gromova OA. Soderzhanie mikrojelementov v nervnoj tkani i ishemicheskij insul’t. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2013;113:3:30-36. (In Russ.).
Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L, Mills D, Brown MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, Holder JC. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol. 2000;7(10):793-803. https://doi.org/10.1016/s1074-5521(00)00025-9
Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature. 2000;406(6791):86-90.
Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci. 2003;116(7):1175-1186. https://doi.org/10.1242/jcs.00384
Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol. 2001;65(4):391-426. https://doi.org/10.1016/s0301-0082(01)00011-9
Kaidanovich O, Eldar-Finkelman H. The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Expert Opin Ther Targets. 2002;6(5):555-561. https://doi.org/10.1517/14728222.6.5.555
Inestrosa NC, Varela-Nallar L. Wnt signaling in the nervous system and in Alzheimer’s disease. J Mol Cell Biol. 2014;6(1):64-74. https://doi.org/10.1093/jmcb/mjt051
Mendes CT, Mury FB, De Sa ME et al. Lithium reduces Gsk3b mRNA levels: implications for Alzheimer’s Disease. J Eur Arch Psychiatry Clin Neurosci. 2009;259(1):16-22. https://doi.org/10.1007/s00406-008-0828-5
Aubry JM, Schwald M, Ballmann E, Karege F. Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation. Psychopharmacology (Berl). 2009;205(3):419-429. https://doi.org/10.1007/s00213-009-1551-2
Beurel E, Grieco SF, Jope RS. Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases. Pharmacol Ther. 2014. https://doi.org/10.1016/j.pharmthera.2014.11.016
Huang J, Klionsky D.J. Autophagy and human disease. Cell Cycle. 2007;6(15):1837-1849. https://doi.org/10.4161/cc.6.15.4511
Hallcher LM, Sherman WR. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem. 1980;255:10896-10901.
Ragan CI, Watling KJ, Gee NS, Aspley S, Jackson RG, Reid GG, Baker R, Billington DC, Barnaby RJ, Leeson PD. The dephosphorylation of inositol 1,4-bisphosphate to inositol in liver and brain involves two distinct Li+-sensitive enzymes and proceeds via inositol 4-phosphate. Biochem J. 1988;249:143-148. https://doi.org/10.1042/bj2490143
Berridge MJ, Downes CP, Hanley MR. Neural and developmental actions of lithium: a unifying hypothesis. Cell. 1989;59:411-419. https://doi.org/10.1016/0092-8674(89)90026-3
Hashimoto R, Hough C, Nakazawa T, Yamamoto T, Chuang DM. Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J Neurochem. 2002;80(4):589-597. https://doi.org/10.1046/j.0022-3042.2001.00728.x
Ma J, Zhang GY. Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia. Neurosci Lett. 2003;348(3):185-189. https://doi.org/10.1016/s0304-3940(03)00784-5
Maiuri MC, Criollo A, Tasdemir E, Vicencio JM, Tajeddine N, Hickman JA, Geneste O, Kroemer G. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy. 2007;3(4):374-376. https://doi.org/10.4161/auto.4237
Chen RW, Chuang DM. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem. 1999;274(10):6039-6042. https://doi.org/10.1074/jbc.274.10.6039
Hiroi T, Wei H, Hough C, Leeds P, Chuang DM. Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells: roles of intracellular calcium, GRP78 and Bcl-2. Pharmacogenomics J. 2005;5(2):102-111. https://doi.org/10.1038/sj.tpj.6500296
Zhou R, Yuan P, Wang Y, Hunsberger JG, Elkahloun A, Wei Y, Damschroder-Williams P, Du J, Chen G, Manji HK. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology. 2009;34(6):1395-1405.
Frey BN, Andreazza AC, Cereser KM, Martins MR, Valvassori SS, Reus GZ, Quevedo J, Kapczinski F. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci. 2006;79(3):281-286. https://doi.org/10.1016/j.lfs.2006.01.002
Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology. 2001;158(1):100-106. https://doi.org/10.1007/s002130100871
Rantamaki T, Knuuttila JE, Hokkanen ME, Castren E. The effects of acute and long-term lithium treatments on trkB neurotrophin receptor activation in the mouse hippocampus and anterior cingulate cortex. Neuropharmacology. 2006;50(4):421-417. https://doi.org/10.1016/j.neuropharm.2005.10.001
Manji HK, Chen G. Pkc, map kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Mol Psychiatry. 2002;7(suppl 1):46-56. https://doi.org/10.1038/sj.mp.4001018
Chen G, Huang LD, Zeng WZ, Manji HK. Mood stabilizers regulate cytoprotective and mRNA-binding proteins in the brain: long-term effects on cell survival and transcript stability. Int J Neuropsychopharmacol. 2001;4:47-64. https://doi.org/10.1017/s146114570100222x
Dwivedi T, Zhang H. Lithium-induced neuroprotection is associated with epigenetic modification of specific BDNF gene promoter and altered expression of apoptotic-regulatory proteins. Front Neurosci. 2015;8:457. https://doi.org/10.3389/fnins.2014.00457
Guo S, Arai K, Stins MF, Chuang DM, Lo EH. Lithium upregulates vascular endothelial growth factor in brain endothelial cells and astrocytes. Stroke. 2009;40(2):652-655. https://doi.org/10.1161/strokeaha.108.524504
Bian Q, Shi T, Chuang DM et al. Lithium reduces ischemia-induced hippocampal CA1 damage and behavioral deficits in gerbils. J Brain Res. 2007;1184:270-276. https://doi.org/10.1016/j.brainres.2007.09.054
Xu J, Culman J, Blume A et al. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke. 2003;34(5):1287-1292. https://doi.org/10.1161/01.str.0000066308.25088.64
Chalecka-Franaszek E, Chuang DM. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. J Proc Natl Acad Sci USA. 1999;96(15):8745-8750. https://doi.org/10.1073/pnas.96.15.8745
Roh MS, Eom TY, Zmijewska AA et al. Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine. J Biol Psychiatry. 2005;57(3):278-286. https://doi.org/10.1016/j.biopsych.2004.10.039
Nonaka S, Chuang DM. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. J Neuroreport. 1998;9(9):2081-2084. https://doi.org/10.1097/00001756-199806220-00031
Xu J, Culman J, Blume A et al. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke. 2003;34(5):1287-1292. https://doi.org/10.1161/01.str.0000066308.25088.64
Kim YR, Van Meer MP, Tejima E et al. Functional MRI of delayed chronic lithium treatment in rat focal cerebral ischemia. Stroke. 2008;39(2):439-447. https://doi.org/10.1161/strokeaha.107.492215
Xie C, Zhou K, Wang X, Blomgren K, Zhu C. Therapeutic benefits of delayed lithium administration in the neonatal rat after cerebral hypoxia-ischemia. PLoS One. 2014;11(9):0107192. https://doi.org/10.1371/journal.pone.0107192
Gromova OA, Torshin IJu, Gogoleva IV, Pronin AV, Stel’mashuk EV, Genrihs EE, Demidov VI, Volkov AJu, Haspekov LG, Aleksandrova OP. Pharmacokinetic and pharmacodynamic synergy between neuropeptides and lithium in the implementation of the neurotrophic and neuroprotective effects of Cerebrolysin. Journal neurology and psychiatry im. S.S. Korsakova. 2015;115:3.
Forlenza OV, De-Paula VJ, Diniz BS. Neuroprotective Effects of Lithium: Implications for the Treatment of Alzheimer’s Disease and Related Neurodegenerative Disorders. ACS Chem Neurosci. 2014. https://doi.org/10.1021/cn5000309
Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L, Manji HK, Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci. 2003;23:7311-7316.
Angelucci F, Aloe L, Jimenez-Vasquez P, Mathe AA. Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression. Int J Neuropsychopharmacol. 2003;6:225-231. https://doi.org/10.1017/s1461145703003468
Fu ZQ, Yang Y, Song J, Jiang Q, Lin ZC, Wang Q, Tian, Q. LiCl attenuates thapsigargin-induced tau hyperphosphorylation by inhibiting GSK-3β in vivo and in vitro. J Alzheimer’s Dis. 2010;21(4):1107-1117.
Esselmann H, Maler JM, Kunz N, Otto M, Paul S, Lewczuk P, Ruther E, Kornhuber J, Wiltfang, J. Lithium decreases secretion of Aβ1-42 and C-truncated species Aβ1-37/38/39/40 in chicken telencephalic cultures but specifically increases intracellular Aβ1-38. Neurodegener Dis. 2004;1(4-5):236-241. https://doi.org/10.1159/000080992
Phiel CJ, Wilson CA, Lee VM, Klein PS. GSK-3alpha regulates production of Alzheimer’s disease amyloid-β peptides. Nature. 2003;423(6938):435-439. https://doi.org/10.1038/nature01640
Hashimoto R, Senatorov V, Kanai H, Leeds P, Chuang DM. Lithium stimulates progenitor proliferation in cultured brain neurons. Neuroscience. 2003;117(1):55-61. https://doi.org/10.1016/s0306-4522(02)00577-8
Kim JS, Chang MY, Yu IT, Kim JH, Lee SH, Lee YS, Son H. Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo. J Neurochem. 2004;89(2):324-336. https://doi.org/10.1046/j.1471-4159.2004.02329.x
Ngok-Ngam P, Watcharasit P, Thiantanawat A, Satayavivad J. Pharmacological inhibition of GSK3 attenuates DNA damage-induced apoptosis via reduction of p53 mitochondrial translocation and Bax oligomerization in neuroblastoma SH-SY5Y cells. Cell Mol Biol Lett. 2013;18(1):58-74. https://doi.org/10.2478/s11658-012-0039-y
Nahman S, Belmaker RH, Azab AN. Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells. Innate Immun. 2012;18(3):447-458. https://doi.org/10.1177/1753425911421512
Basselin M, Villacreses NE, Lee HJ, Bell JM, Rapoport SI. Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation. J Neurochem. 2007;102(3):761-772. https://doi.org/10.1111/j.1471-4159.2007.04593.x
Schwartz M, Kipnis J, Rivest S, Prat A. How do immune cells support and shape the brain in health, disease, and aging? J Neurosci. 2013;33(45):17587-17596. https://doi.org/10.1523/jneurosci.3241-13.2013
Hickey MA, Chesselet MF. Apoptosis in Huntington’s disease. J Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(2):255-265.
Taylor-Robinson SD, Weeks RA, Bryant DJ et al. Proton magnetic resonance spectroscopy in Huntington’s disease: evidence in favour of the glutamate excitotoxic theory. J Mov Disord. 1996;11(2):167-173. https://doi.org/10.1002/mds.870110209
Senatorov VV, Ren M, Kanai H, Wei H, Chuang DM. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington’s disease. J Molecular Psychiatry. 2004;9(4):371-385. https://doi.org/10.1038/sj.mp.4001463
Gordon PH. Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management. CNS Drugs. 2011;25(1):1-15. https://doi.org/10.2165/11586000-000000000-00000
Dill J, Wang H, Zhou F, Li S. Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J Neurosci. 2008;28:8914-8928. https://doi.org/10.1523/jneurosci.1178-08.2008
Strong MJ. The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotrophic Lateral Scler. 2008;9:323-338. https://doi.org/10.1080/17482960802372371
Busceti CL, Biagioni F, Riozzi B, Battaglia G, Storto M, Cinque C, Molinaro G, Gradini R, Caricasole A, Canudas AM, Bruno V, Nicoletti F, Fornai F. Enhanced tau phosphorylation in the hippocampus of mice treated with 3,4-methylenedioxymethamphetamine. J Neurosci. 2008;28:3234-3245. https://doi.org/10.1523/jneurosci.0159-08.2008
Feng HL, Leng Y, Ma CH, Zhang J, Ren M, Chuang DM. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience. 2008;155(3):567-572. https://doi.org/10.1016/j.neuroscience.2008.06.040
Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, Manca ML. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2008;105(6):2052-2057. https://doi.org/10.1073/pnas.0708022105
Solsona MD, Fernández LL, Boquet EM, Andrés JL. Lithium citrate as treatment of Canavan disease. Clin Neuropharmacol. 2012;35(3):150-151. https://doi.org/10.1097/wnf.0b013e3182515c9d
Assadi M, Janson C, Wang DJ, Goldfarb O, Suri N, Bilaniuk L, Leone P. Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease. Eur J Paediatr Neurol. 2010;14(4):354-359. https://doi.org/10.1016/j.ejpn.2009.11.006
Beurel E, Michalek SM, Jope RS. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol. 2010;31(1):24-31. https://doi.org/10.1016/j.it.2009.09.007
De Sarno P, Axtell RC, Raman C et al. Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J Immunol. 2008;181(1):338-345. https://doi.org/10.4049/jimmunol.181.1.338
Yick LW, So KF, Cheung PT, Wu WT. Lithium chloride reinforces the regeneration-promoting effect of chondroitinase ABC on rubrospinal neurons after spinal cord injury. J Neurotrauma. 2004;21:932-943. https://doi.org/10.1089/neu.2004.21.932
Su H, Zhang W, Guo J, Guo A, Yuan Q, Wu W. Lithium enhances the neuronal differentiation of neural progenitor cells in vitro and after transplantation into the avulsed ventral horn of adult rats through the secretion of brain-derived neurotrophic factor. J Neurochem. 2009;108:1385-1398. https://doi.org/10.1111/j.1471-4159.2009.05902.x
Su H, Chu TH, Wu W. Lithium enhances proliferation and neuronal differentiation of neural progenitor cells in vitro and after transplantation into the adult rat spinal cord. Exp Neurol. 2007;206:296-307. https://doi.org/10.1016/j.expneurol.2007.05.018
Dill J, Wang H, Zhou F, Li S. Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J Neurosci. 2008;28:8914-8928. https://doi.org/10.1523/jneurosci.1178-08.2008
Leeds PR, Yu F, Wang Z, Chiu CT, Zhang Y, Leng Y, Linares GR, Chuang DM. A New Avenue for Lithium: Intervention in Traumatic Brain Injury. ACS Chem Neurosci. 2014. https://doi.org/10.1021/cn500040g
Appleby BS. Psychotropic medications and the treatment of human prion diseases. CNS Neurol Disord Drug Targets. 2009;8:353-362. https://doi.org/10.2174/187152709789541961
Heiseke A, Aguib Y, Riemer C, Baier M, Schatzl HM. Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy. J Neurochem. 2009;109:25-34. https://doi.org/10.1111/j.1471-4159.2009.05906.x
Heiseke A, Aguib Y, Riemer C, Baier M, Schatzl HM. Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy. J Neurochem. 2009;109:25-34. https://doi.org/10.1111/j.1471-4159.2009.05906.x
Bianchi P, Ciani E, Contestabile A, Guidi S, Bartesaghi R. Lithium restores neurogenesis in the subventricular zone of the Ts65Dn Mouse, a model for Down syndrome. Brain Pathol. 2009;20:106-118. https://doi.org/10.1111/j.1750-3639.2008.00246.x
van Harten PN, Hoek HW, Matroos GE, van OJ. Evidence that lithium protects against tardive dyskinesia: the Curacao Extrapyramidal syndromes study VI. Eur Neuropsychopharmacol. 2008;18:152-155. https://doi.org/10.1016/j.euroneuro.2007.07.004
Mo M, Erdelyi I, Szigeti-Buck K, Benbow JH, Ehrlich BE. Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment. FASEB J. 2012;26(11):4696-4709. https://doi.org/10.1096/fj.12-214643
Alimoradi H, Pourmohammadi N, Mehr SE, Hassanzadeh G, Hadian MR, Sharifzadeh M, Bakhtiarian A, Dehpour AR. Effects of lithium on peripheral neuropathy induced by vincristine in rats. Acta Med Iran. 2012;50(6):373-379.
Chen K, Wu Y, Zhu M, Deng Q, Nie X, Li M, Wu M, Huang X. Lithium chloride promotes host resistance against Pseudomonas aeruginosa keratitis. Mol Vis. 2013;19:1502-1514.